Microplate Dx Limited

Improving quality of life for patients by providing antimicrobial stewardship in a cost-effective manner.

Founded 2021

Glasgow, United Kingdom 13 employees Seed Total: $2.50M Biotechnology, Health Care

Microplate Dx Limited is a UK-based startup that aims to revolutionize antibiotic susceptibility testing diagnostics. Founded in 2021, the company's mission is to improve the quality of life for patients by providing antimicrobial stewardship in a cost-effective manner. Their flagship platform diagnostic test enables rapid antibiotic susceptibility testing at the point-of-care, allowing clinicians to confidently select the most effective antibiotic for a patient's infection in just minutes, a vast improvement over the current 2-day standard. This breakthrough technology not only saves valuable time but also addresses the critical global health issue of antimicrobial resistance, ultimately saving lives. In September 2023, Microplate Dx Limited secured a significant £2.50M Seed Round investment from a group of noteworthy investors including SIS Ventures, Scottish Enterprise, Deepbridge Capital, Thairm Bio, and the University of Strathclyde. This injection of capital underlines the confidence that these prominent investors have in the potential of the company's innovative approach to combatting antimicrobial resistance. Microplate Dx Limited operates within the biotechnology and healthcare industries and is poised to make a substantial impact in the fight against antimicrobial resistance, setting the stage for future growth and success.

Funding Stage	Amount	Investors	Lead Investors	Date
Seed Round	£2.50M	5	SIS Ventures, Scottish Enterprise +3	11 Sep 2023

Funding Stage

Amount

Investors

Lead Investors

Date

Seed Round

£2.50M

SIS Ventures, Scottish Enterprise +3

11 Sep 2023

FAQ About Microplate Dx Limited

Improving quality of life for patients by providing antimicrobial stewardship in a cost-effective manner.

Microplate Dx Limited was founded in 2021.

Microplate Dx Limited is headquartered in Glasgow, United Kingdom.

Microplate Dx Limited operates in Biotechnology and Health Care. Its work centres on antimicrobial stewardship, rapid antibiotic susceptibility testing, point-of-care diagnostics and antimicrobial resistance.

Microplate Dx Limited has approximately 13 employees.

Microplate Dx Limited has completed 1 funding round, raising a total of $2.50M. The latest funding stage is Seed.

Top alternatives and competitors to Microplate Dx Limited include Pathnostics - A Diagnostics Solutions Company, First Light Diagnostics, EMPE Diagnostics, Pattern Bioscience, MeMed . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Microplate Dx Limited and Pathnostics - A Diagnostics Solutions Company are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Microplate Dx Limited

Funding Rounds & Investors (1)

Microplate Dx Limited Alternatives & Competitors

FAQ About Microplate Dx Limited